Other Cancers Pomalidomide, Daratumumab, and Dexamethasone Show Favorable Outcomes In RRMM Patients Sep 28, 2023
Other Cancers Assessment of KL590586, an Advanced Selective RET Inhibitor, in Patients with RET-Altered Solid Tumors Sep 28, 2023
